Effects of luteolin on canine osteosarcoma: Suppression of cell proliferation and synergy with cisplatin

Soomin Ryu, Sunwoo Park, Whasun Lim, Gwonhwa Song

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


Canine osteosarcoma is characterized by aggressiveness, easy metastasis to the lungs, and high mortality after standard therapy. Luteolin is a flavonoid found in vegetables and fruits and has diverse functions. Elucidation of the biological mechanisms of luteolin on canine osteosarcoma will enhance the efficacy of chemotherapeutic agents in canine tumors. In this study, we examined the effects of luteolin in the canine osteosarcoma cell lines, D17 and DSN. The results of this study show that luteolin inhibited canine osteosarcoma cell proliferation and induced apoptosis by altering cell-cycle proportion, producing reactive oxygen species, increasing the loss of mitochondrial membrane potential, and reducing cytosolic Ca2+ concentration. In addition, luteolin activated ERK1/2 and inactivated phosphoinositide 3-kinase/AKT signaling in canine osteosarcoma cells. Moreover, luteolin showed synergistic effects with cisplatin to reduce cell proliferation. In summary, luteolin induced cell death by initiating mitochondrial dysfunction and regulating intracellular signal transduction in canine osteosarcoma cells.

Original languageEnglish
Pages (from-to)9504-9514
Number of pages11
JournalJournal of Cellular Physiology
Issue number6
Publication statusPublished - 2019 Jun


  • apoptosis
  • canine osteosarcoma
  • cell signaling
  • luteolin
  • mitochondrial dysfunction

ASJC Scopus subject areas

  • Physiology
  • Clinical Biochemistry
  • Cell Biology


Dive into the research topics of 'Effects of luteolin on canine osteosarcoma: Suppression of cell proliferation and synergy with cisplatin'. Together they form a unique fingerprint.

Cite this